Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
17 December 1996Website:
http://www.questdiagnostics.comNext earnings report:
23 July 2024Last dividends:
05 April 2024Next dividends:
08 July 2024Price
after hours | Wed, 03 Jul 2024 19:20:21 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
DGX Latest News
By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for Canadians.
Quest Diagnostics said on Wednesday it would acquire LifeLabs, a provider of community laboratory tests, from OMERS for about C$1.35 billion, or about $985 million.
Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics' laboratory services across Minnesota and western Wisconsin.
SECAUCUS, N.J. , June 27, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today released its 2023 Corporate Responsibility Report.
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovative offerings.
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer diagnosis.
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Investors are feeling positive about Quest Diagnostics (DGX) due to its strong growth in its core business.
Quest Diagnostics' recent deal combines its oncology knowledge and size with PathAI's advancements in AI and digital pathology.
The government has implemented a rule that will require makers of previously unregulated medical tests to demonstrate the accuracy of their products within four years, despite strong opposition from the testing industry.
What type of business is Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated is one of the leading providers of diagnostic services headquartered in Secaucus, New Jersey. The company specializes in diagnostics for cancer, cardiovascular and infectious diseases, as well as neurological disorders, COVID-19, and conducts forensic drug testing. It was founded in 1967 as Metropolitan Pathology Laboratory, Inc. The company's activities are divided into two directions: Diagnostic information services - provides diagnostic services and analytical data to a wide range of clients, including patients, physicians, hospitals, employers, and others. Diagnostic solutions - provides services for assessing risks in the life insurance industry.
What sector is Quest Diagnostics Incorporated in?
Quest Diagnostics Incorporated is in the Healthcare sector
What industry is Quest Diagnostics Incorporated in?
Quest Diagnostics Incorporated is in the Diagnostics & Research industry
What country is Quest Diagnostics Incorporated from?
Quest Diagnostics Incorporated is headquartered in United States
When did Quest Diagnostics Incorporated go public?
Quest Diagnostics Incorporated initial public offering (IPO) was on 17 December 1996
What is Quest Diagnostics Incorporated website?
https://www.questdiagnostics.com
Is Quest Diagnostics Incorporated in the S&P 500?
Yes, Quest Diagnostics Incorporated is included in the S&P 500 index
Is Quest Diagnostics Incorporated in the NASDAQ 100?
No, Quest Diagnostics Incorporated is not included in the NASDAQ 100 index
Is Quest Diagnostics Incorporated in the Dow Jones?
No, Quest Diagnostics Incorporated is not included in the Dow Jones index
When does Quest Diagnostics Incorporated report earnings?
The next expected earnings date for Quest Diagnostics Incorporated is 23 July 2024